Lipid biomarkers of glioma cell growth arrest and cell death detected by 1H magic angle spinning MRS

NMR in Biomedicine

Volumn 25, Issue 11, 2012, Pages 1253-1262

  Mirbahai, Ladan ^a   Wilson, Martin ^a   Shaw, Christopher S ^a   Mcconville, Carmel ^a   Malcomson, Roger D G ^b   Kauppinen, Risto A ^c   Peet, Andrew C ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

1H magic angle spinning NMR spectroscopy; Apoptosis; Biomarkers; Cell growth arrest; Lipid alterations; Lipid droplets

Indexed keywords

ANNEXINS; APOPTOTIC; CANCER THERAPY; CELL STRESS; CELL-CYCLE ARREST; CHEMOTHERAPEUTIC AGENTS; CIS-PLATIN; CLINICAL USE; DNA LADDERING; GLIOMA CELLS; GROWTH ARREST; GROWTH CYCLE; HIGH RESOLUTION MAGIC ANGLE SPINNING; IN-VITRO; IN-VIVO; LIPID ALTERATION; LIPID BIOMARKERS; LIPID DROPLETS; MAGIC ANGLE SPINNING NMR; NECROTIC CELLS; NEUTRAL LIPID; NILE RED; NMR SPECTROMETER; PROPIDIUM IODIDE; TIME POINTS; TIME-DOMAIN FITTING; VIABLE CELLS;

BIOMARKERS; CELL DEATH; DROPS; FLOW CYTOMETRY; GROWTH KINETICS; LIPIDS; MAGIC ANGLE SPINNING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PLATINUM COMPOUNDS; POLYUNSATURATED FATTY ACIDS; SPECTROMETERS; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

CELL GROWTH;

4',6 DIAMIDINO 2 PHENYLINDOLE; BIOLOGICAL MARKER; CISPLATIN; DYE; FAT DROPLET; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; POLYUNSATURATED FATTY ACID; PROPIDIUM IODIDE; SATURATED FATTY ACID; TRYPAN BLUE;

ALGORITHM; ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL DEATH; CELL GROWTH; CELL STRESS; CONTROLLED STUDY; DNA DETERMINATION; FLOW CYTOMETRY; GLIOMA CELL; LIPID METABOLISM; MAGIC ANGLE SPINNING; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RAT; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT RESPONSE;

ANIMALS; ANNEXIN A5; BRAIN NEOPLASMS; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; CISPLATIN; DNA FRAGMENTATION; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; GLIOMA; INDOLES; LIPIDS; MAGNETIC RESONANCE SPECTROSCOPY; OXAZINES; PROPIDIUM; PROTONS; RATS; STAINING AND LABELING; TRYPAN BLUE; TUMOR MARKERS, BIOLOGICAL;

RATTUS;

EID: 84868115142     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2796     Document Type: Article

References (37)

1. Milkevitch M, Shim H, Pilatus U, Pickup S, Wehrle JP, Samid D, Poptani H, Glickson JD, Delikatny EJ. Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells. Biochim. Biophys. Acta 2005; 1734: 1-12.
2. Sapunar F, Smith IE. Neoadjuvant chemotherapy for breast cancer. Ann. Med. 2000; 32: 43-50.
3. 1H NMR spectroscopy. Cell Death Differ. 2001; 8: 219-224.
4. Shulman RG, Rothman DL, Blamire AM. NMR studies of human brain function. Trends Biochem. Sci. 1994; 19: 522-526.
5. 1H NMR spectroscopy. J. Biol. Chem. 1992; 267: 9905-9910.
6. Robinson SP, Barton SJ, McSheehy PM, Griffiths JR. Nuclear magnetic resonance spectroscopy of cancer. Br. J. Radiol. 1997; 70(Spec No): S60-S69.
7. 31P measurements of response to treatment. NMR Biomed. 1998; 11: 314-340.
8. Gill SS, Thomas DG, Van Bruggen N, Gadian DG, Peden CJ, Bell JD, Cox IJ, Menon DK, Iles RA, Bryant DJ, Coutts GA. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J. Comput. Assist. Tomogr. 1990; 14: 497-504.
9. 1H MR spectroscopy. Radiology 1992; 183: 701-709.
10. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed. 1992; 5: 303-324.
11. Mountford CE, Wright LC, Holmes KT, Mackinnon WB, Gregory P, Fox RM. High-resolution proton nuclear magnetic resonance analysis of metastatic cancer cells. Science 1984; 226: 1415-1418.
12. 1H-NMR detectable mobile lipid in stimulated lymphocytes: relationship to cellular activation, the cell cycle, and phosphatidylcholine-specific phospholipase C. Biochem. Biophys. Res. Commun. 1997; 239: 868-874.
13. 1H NMR visible lipids in the life and death of cells. Trends Biochem. Sci. 2000; 25: 357-362.
14. 1H MRS of high grade astrocytomas: mobile lipid accumulation in necrotic tissue. NMR Biomed. 1994; 7: 149-155.
15. Blankenberg FG, Storrs RW, Naumovski L, Goralski T, Spielman D. Detection of apoptotic cell death by proton nuclear magnetic resonance spectroscopy. Blood 1996; 87: 1951-1956.
16. 1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma: implications for the in vivo detection of apoptosis. Nat. Med. 1999; 5: 1323-1327.
17. Delikatny EJ, Cooper WA, Brammah S, Sathasivam N, Rideout DC. Nuclear magnetic resonance-visible lipids induced by cationic lipophilic chemotherapeutic agents are accompanied by increased lipid droplet formation and damaged mitochondria. Cancer Res. 2002; 62: 1394-1400.
18. 1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cells. Biochim. Biophys. Acta, 2001; 1530: 47-66.
19. Blankenberg FG, Katsikis PD, Storrs RW, Beaulieu C, Spielman D, Chen JY, Naumovski L, Tait JF. Quantitative analysis of apoptotic cell death using proton nuclear magnetic resonance spectroscopy. Blood 1997; 89: 3778-3786.
20. Al-Saffar NM, Titley JC, Robertson D, Clarke PA, Jackson LE, Leach MO, Ronen SM. Apoptosis is associated with triacylglycerol accumulation in Jurkat T-cells. Br. J. Cancer 2002; 86: 963-970.
21. 1H MR-visible lipid in human glioma cells is independent of the cell cycle. Int. J. Oncol. 1997; 11: 543-550.
22. 1H NMR spectra of a myeloma cell line correlates with the induced formation of cytoplasmic lipid droplets. Magn. Reson. Med. 1993; 29: 546-550.
23. 1H nuclear magnetic resonance visible polyunsaturated fatty acids in BT4C gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death. Cancer Res. 2003; 63: 3195-3201.
24. Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 2003; 22: 7265-7279.
25. Reynolds G, Wilson M, Peet A, Arvanitis TN. An algorithm for the automated quantitation of metabolites in in vitro NMR signals. Magn. Reson. Med. 2006; 56: 1211-1219.
26. Opstad KS, Bell BA, Griffiths JR, Howe FA. Toward accurate quantification of metabolites, lipids, and macromolecules in HRMAS spectra of human brain tumor biopsies using LCModel. Magn. Reson. Med. 2008; 60: 1237-1242.
27. Dunn JCY, Yinting C, Qin HH, Zupekan T. Transplantation of adrenal cortical progenitor cells enriched by Nile red. J. Surg. Res. 2009; 156(2): 317-324.
28. Greenspan P, Mayer EP, Fowler SD. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 1985; 100: 965-973.
29. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 1984; 142: 67-77.
30. Qin LF, Ng IO. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett. 2002; 175: 27-38.
31. Barba I, Cabanas ME, Arus C. The relationship between nuclear magnetic resonance-visible lipids, lipid droplets, and cell proliferation in cultured C6 cells. Cancer Res. 1999; 59: 1861-1868.
32. Jackowski S. Cell cycle regulation of membrane phospholipid metabolism. J. Biol. Chem. 1996; 271: 20 219-20 222.
33. Jackowski S. Coordination of membrane phospholipid synthesis with the cell cycle. J. Biol. Chem. 1994; 269: 3858-3867.
34. Delikatny EJ, Lander CM, Jeitner TM, Hancock R, Mountford CE. Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response. Int. J. Cancer 1996; 65: 238-245.
35. 1H MR spectrum in murine T cells and B cells occurs in G1 phase of the cell cycle. Magn. Reson. Med. 1990; 16: 1-8.
36. Quintero M, Cabañas ME, Arús CA. Possible cellular explanation for the NMR-visible mobile lipid (ML) changes in cultured C6 glioma cells with growth. Biochim. Biophys. Acta 2007; 1771: 31-44.
37. 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblasts. Biochim. Biophys. Acta 1999; 1438: 329-348.